Carole Ben-Maimon - 17 May 2023 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
17 May 2023
Net transactions value
+$18,525
Form type
4
Filing time
18 May 2023, 14:13:12 UTC
Previous filing
02 Feb 2023
Next filing
19 Jan 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $18,525 +5,000 +1.9% $3.70 266,829 17 May 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.